If you are:
FDB Only When Necessary: AVAILABLE DATA SUGGEST NO KNOWN RISK; OTC PRODUCT, NO FDA PREGNANCY WARNINGS
No Known Risk: LOW LEVELS EXCRETED WITH LOW RISK FOR ADVERSE EFFECTS IN INFANT
Precaution: LIMITED DATA SUGGEST INCREASED DROWSINESS, AND IRRITABILITY
An adult over 60:
management or monitoring precaution: Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Maximum of 25mg/day. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
management or monitoring precaution: Hepatic-Elderly are more susceptible to hepatotoxicity. Strict adherence to a maximum daily dose of 3000mg is advised.
Giving ACETAMINOPHEN-DIPHENHYDRAMINE to a child under 12:
management or monitoring precaution: Use weight based dosing in children less than 12 years.
Severe Precaution: Use with caution and with clinician consultation. Risk of adverse CNS effects includes sedation or paradoxical excitation.
management or monitoring precaution: Use with caution and with clinician consultation. Risk of adverse CNS effects include sedation or paradoxical excitation.
Contraindication: Possible risk of CNS excitation, convulsions in newborns.